Showing results (1-10 of 229) with videos related to
Sort By:
Pageof 23
The New England Journal of Medicine|October 13, 2016
Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening EffectivenessH Gilbert Welch, Philip C Prorok, A James O'Malley, et al.BMC Medical Research Methodology|September 20, 2002
Statistical issues in randomized trials of cancer screeningStuart G Baker, Barnett S Kramer, Philip C ProrokDisease Markers|August 24, 2004
Development tracks for cancer prevention markersStuart G Baker, Barnett S Kramer, Philip C ProrokJournal of Medical Screening|September 24, 2015
Study designs for determining and comparing sensitivities of disease screening testsPhilip C Prorok, Barnett S Kramer, Anthony B MillerJournal of Medical Screening|October 18, 2008
Early reporting for cancer screening trialsStuart G Baker, Barnett S Kramer, Philip C ProrokBMC Medical Research Methodology|April 12, 2003
Using observational data to estimate an upper bound on the reduction in cancer mortality due to periodic screeningStuart G Baker, Diane Erwin, Barnett S Kramer, et al.Reviews on Recent Clinical Trials|August 5, 2015
The PLCO Cancer Screening Trial: Background, Goals, Organization, Operations, ResultsJohn K Gohagan, Philip C Prorok, Peter Greenwald, et al.Biometrics|September 2, 2004
Estimating the cumulative risk of a false-positive test in a repeated screening programJian-Lun Xu, Richard M Fagerstrom, Philip C Prorok, et al.Clinical Trials (London, England)|June 24, 2010
Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening TrialPaul F Pinsky, Amanda Blacka, Barnett S Kramer, et al.Journal of the National Cancer Institute|February 10, 2015
Conceptualizing overdiagnosis in cancer screeningPamela M Marcus, Philip C Prorok, Anthony B Miller, et al.Pageof 23